Repligen Stock Analysis

Repligen Stock Analysis Notes

About 94.0% of the company shares are owned by institutional investors. The book value of Repligen was at this time reported as 37.01. The company has Price/Earnings To Growth (PEG) ratio of 2.59. Repligen last dividend was issued on the 29th of October 2010. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people. To find out more about Repligen contact Anthony Hunt at 781 250 0111 or learn more at https://www.repligen.com.

Repligen Investment Alerts

Repligen Largest EPS Surprises

View All Earnings Estimates

Repligen Environmental, Social, and Governance (ESG) Scores

Repligen Stock Institutional Investors

Note, although Repligen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Repligen Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.46 B.

Repligen Profitablity

Management Efficiency

Repligen has return on total asset (ROA) of 0.013 % which means that it generated a profit of $0.013 on every $100 spent on assets. This is way below average. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 4th of February 2026, Return On Tangible Assets is likely to drop to -0.02. In addition to that, Return On Capital Employed is likely to drop to -0.01. At this time, Repligen's Net Tangible Assets are very stable compared to the past year. As of the 4th of February 2026, Intangibles To Total Assets is likely to grow to 0.50, while Non Currrent Assets Other are likely to drop about 742.1 K.

Technical Drivers

As of the 4th of February, Repligen holds the Risk Adjusted Performance of 0.0203, semi deviation of 1.95, and Coefficient Of Variation of 5325.24. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them.

Repligen Price Movement Analysis

Repligen Insider Trading Activities

Repligen Outstanding Bonds

Repligen Predictive Daily Indicators

Repligen Corporate Filings

Repligen Forecast Models

Repligen's time-series forecasting models are one of many Repligen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repligen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Repligen Debt to Cash Allocation

Repligen currently holds 686.25 M in liabilities with Debt to Equity (D/E) ratio of 0.23, which may suggest the company is not taking enough advantage from borrowing. Repligen has a current ratio of 2.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Repligen's use of debt, we should always consider it together with its cash and equity.

Repligen Short Long Term Debt Total Over Time

Repligen Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Repligen uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Repligen Debt Ratio

18.0

It appears that most of the Repligen's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Repligen's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Repligen, which in turn will lower the firm's financial flexibility.

Repligen Corporate Bonds Issued

Repligen Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Repligen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Repligen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Repligen. By using and applying Repligen Stock analysis, traders can create a robust methodology for identifying Repligen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Repligen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Repligen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Repligen stock analysis indicators help investors evaluate how Repligen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Repligen shares will generate the highest return on investment. By understating and applying Repligen stock analysis, traders can identify Repligen position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.

It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.